Back to search

Article

Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma

2022-12-19

Abstract excerpt

The clinical use of cisplatin (DDP) is severely restricted because of nonspecific delivery and the induction of serious systemic toxicity. The limited anticancer drug library and the frequent occurrence of multidrug resistance (MDR) have made monotherapy difficult. Strategies to overcome cisplatin resistance and reduce the long-term use of high-dose medicines, as well as strategies for targeted therapy against hep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aca23556-e696-5bca-b7d7-f61448da0691
DOI
10.21203/rs.3.rs-2378010/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinomaDOI 10.21203/rs.3.rs-2378010/v1
Nanomedicine Strategies to Overcome Multi-Drug Resistance in Cancer: Innovations in Targeted Delivery, Tumor Microenvironment Modulation and Synergistic TherapiesSemantic proximity
Platinum Complexes as Anticancer AgentsSemantic proximity
Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.Semantic proximity
A super-assembled synergistically nanoplatform AP@ZIF-8 Pt for hepatocarcinoma therapySemantic proximity
Multi-mechanistic mitochondria-mediated N-methylated YKWYYRGAA-decorated nano-chitosan conjugate carrier for treatment of NRAS-mutant-harbouring lung carcinoma.Semantic proximity
Engineered Exosomes for the Targeted Delivery of A Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma.Semantic proximity
pH-Sensitive Shell–Core Platform Block DNA Repair Pathway To Amplify Irreversible DNA Damage of Triple Negative Breast CancerSemantic proximity
Targeting hepatocellular carcinoma with aptamers: from biomarker detection to therapeutic applicationsSemantic proximity
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian CancersSemantic proximity
Nanomaterials for reversion of multidrug resistance in cancer: a new hope for an old idea?Semantic proximity
Abplatin(IV) Inhibited Tumor Growth On A Patient Derived Cancer Model of Hepatocellular Carcinoma And Its Comparative Multi-Omics Study With CisplatinSemantic proximity
A Targeted Octahedral DNA Nanostructure Co-delivers siME3 and Doxorubicin to Enhance Collateral Lethality in ME2-Deficient Pancreatic CancerSemantic proximity
Select a neighboring publication to make it the new centre.